Bernat Olle

Chief Executive Officer and Co-founder at Vedanta Biosciences, Inc.

Bernat Olle is a prominent figure in the biotech industry, particularly in the field of microbiome therapeutics. He is the Chief Executive Officer, Co-founder, and member of the Board of Directors at Vedanta Biosciences, Inc., a company he has been leading since September 2015.1

Professional Background

Bernat Olle's career in the life sciences sector is extensive:

Vedanta Biosciences:

Co-founded the company in February 2012
Became CEO in September 2015
Leads the development of oral therapies based on defined consortia of bacteria isolated from the human microbiome1

PureTech Health:

Served as a Venture Partner from July 2007 to November 2016
Held various positions, including Principal, Senior Associate, and Associate1

Follica, Inc.:

Co-founder and Board member from June 2007 to January 2015
Involved in developing novel treatments for androgenetic alopecia1

Education

Bernat Olle has a strong educational background in chemical engineering and business:

PhD and MS in Chemical Engineering Practice from Massachusetts Institute of Technology (MIT)
MBA from MIT Sloan School of Management
B.Eng. in Chemical Engineering from Universitat Rovira i Virgili1

Achievements and Recognition

Throughout his career, Bernat Olle has received numerous accolades:

Named Spanish Innovator of the Year under 35 by MIT Technology Review in 2013
Recipient of the 2019 Immigrant Entrepreneur Award in Life Sciences
Finalist for the Entrepreneur Of The Year® 2018 New England
Named one of Boston Business Journal's 2018 40 Under 40 honorees
Recognized as a Pharma Exec Emerging Pharma Leader in 20181

Bernat Olle's work at Vedanta Biosciences focuses on developing innovative microbiome-based therapeutics, with potential applications in areas such as C. difficile infection prevention, inflammatory bowel diseases, food allergies, and liver disease.1 His leadership has helped position Vedanta as a pioneer in the field of microbiome therapeutics, with a substantial patent portfolio and advanced capabilities in bacterial consortia drug development.

Experience

Chief Executive Officer, Co-founder, Board of Directors at Vedanta Biosciences, Inc. (September 2015 - Present)

Venture Partner at PureTech Health (July 2007 - November 2016), Co-founder, Board of Directors at Follica, Inc. (June 2007 - January 2015), Station Director at Singapore-MIT Alliance for Research & Technology (March 2004 - April 2004)

Education

MBA in Business from MIT Sloan School of Management (2005 - 2007), PhD in Chemical Engineering Practice from Massachusetts Institute of Technology (2002 - 2007), M.S. in Chemical Engineering Practice from Massachusetts Institute of Technology (2002 - 2004), B. Eng. in Chemical Engineering from Universitat Rovira i Virgili (1997 - 2002)